• Controlling gum disease improves blood sugar control in diabetics

    Apr 28, 2006
    Diabetic patients have a higher risk of developing periodontal disease and gum disease is common in diabetics. Researchers in Madrid note that studies since the 1960s show gum disease worsens blood sugar control. The researchers studied patients with moderate but chronic periodontitis in this small but solidf study; half of whom had diabetes and the other half being diabetes free.
  • Resveratrol has aromatase inhibiting activity - another important way that it may help curtail cancer

    Apr 27, 2006
    Many breast tumors are estrogen sensitive meaning the hormone estrogen fuels their growth. Aromatase is the enzyme that changes androgens (testosterone) into estrogen. One way of inhibiting the growth of estrogen sensitive tumors is by using a drug that blocks aromatase.
  • More evidence that Coenzyme Q10 protects the brain

    Apr 25, 2006
    Coenzyme Q10 is manufactured in the body and is needed to create energy. Research shows that Coenzyme Q10 protects the brain, has anti-cancer effects, helps prevent migraine headaches, improves periodontal disease, and protects kidney and heart function while improving blood pressure. The body's manufacture of Coenzyme Q10 begins to drop after the age of about 20 and a number of drugs, particularly the statin drugs, decrease the body's level of Coenzyme Q10.
  • More evidence that Green Tea Extract is very important for diabetics

    Apr 24, 2006
    One of the major effects of diabetes is damage to blood vessel walls leading to cardiovascular disease. The aorta is the main artery that carries oxygenated blood from the heart to the rest of the body. In this study rats were given a single dose of the antibiotic streptozotocin - this drug quickly causes diabetes.
  • Green Tea and Coffee lower the risk of diabetes

    Apr 21, 2006
    In this study Japanese researchers investigated whether Green, Black, or Oolong Teas or Coffee decrease the risk of developing diabetes. A total of 17,413 people were followed for 5 years. The participants ranged in age from 40 to 65 at the start of the study and were free of diabetes, cardiovascular disease and cancer.